基本資料
種類: ETF
費用比率%: 0.80
資產淨值: 32.88
成立日期: 16/11/2022
 
分析
市值分佈:
56.65%
大市值
--
中市值
0.32%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 01/08/2026 05:21) 總持有投資項目: 23  
0%
 
100%
     10大 (49.76%)
代號 名稱 佔比% 持有日期
LLYEli Lilly & Co21.2630/06/2026
GILDGilead Sciences5.0829/07/2026
LEGNLegend Biotech Corp4.4330/06/2026
RYTMRhythm Pharmaceuticals4.2329/07/2026
BSXBoston Scientific Corp3.0329/07/2026
NTRANatera2.7330/06/2026
CORCencora2.7229/07/2026
WGSGeneDx Holdings Corp2.2030/04/2026
PCVXVaxcyte2.1030/06/2026
ARGXargenx SE2.0930/07/2026
DHRDanaher Corp2.0930/06/2026
UNHUnitedhealth Group1.3730/07/2026
VRTXVertex Pharmaceuticals1.2129/07/2026
ALNYAlnylam Pharmaceuticals0.9029/07/2026
RDNTRadNet0.7130/06/2026
PRAXPraxis Precision Medicines0.6529/07/2026
RLAYRelay Therapeutics0.6430/06/2026
IMVTImmunovant0.5730/04/2026
ORKAOruka Therapeutics Inc0.5530/06/2026
NAMSNewAmsterdam Pharma Company NV0.5029/07/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.